Activity of abundant antimicrobials of the human airway. - Wikidata - awgldk - TriplyDB

Activity of abundant antimicrobials of the human airway.

Activity of abundant antimicrobials of the human airway.

http://www.wikidata.org/entity/Q33860518

about

Genetic evidence that antibacterial activity of lysozyme is independent of its catalytic function Antimicrobial proteins and polypeptides in pulmonary innate defence Determinants of Staphylococcus aureus nasal carriage Antimicrobial polypeptides in host defense of the respiratory tract Capsule polysaccharide mediates bacterial resistance to antimicrobial peptides Modulation of in vitro fungicidal activity of human lactoferrin against Candida albicans by extracellular cation concentration and target cell metabolic activity Safety assessment of inhaled xylitol in mice and healthy volunteers Crystal Structure of a Charge Engineered Human Lysozyme Having Enhanced Bactericidal Activity Increased susceptibility to pulmonary Pseudomonas infection in Splunc1 knockout mice Coal fly ash impairs airway antimicrobial peptides and increases bacterial growth Lung infections associated with cystic fibrosis.Enhanced antimicrobial activity of engineered human lysozyme Cirrhosis-induced defects in innate pulmonary defenses against Streptococcus pneumoniae Modulation of gene expression in Actinobacillus pleuropneumoniae exposed to bronchoalveolar fluid.Transcriptional and proteomic responses to carbon starvation in Paracoccidioides.Klebsiella pneumoniae capsule polysaccharide impedes the expression of beta-defensins by airway epithelial cells The osmolyte xylitol reduces the salt concentration of airway surface liquid and may enhance bacterial killing.Common gene therapy viral vectors do not efficiently penetrate sputum from cystic fibrosis patients.Role of the cystic fibrosis transmembrane conductance regulator in innate immunity to Pseudomonas aeruginosa infections.Clinical implications of inflammation in young children.Bactericidal activity of mammalian cathelicidin-derived peptides.Antimycobacterial agent based on mRNA encoding human beta-defensin 2 enables primary macrophages to restrict growth of Mycobacterium tuberculosis Enhanced susceptibility to pulmonary infection with Burkholderia cepacia in Cftr(-/-) mice.Enemy of the (immunosuppressed) state: an update on the pathogenesis of Aspergillus fumigatus infection.Bronchoalveolar fluid is not a major hindrance to virus-mediated gene therapy in cystic fibrosis.The host defense peptide beta-defensin 1 confers protection against Bordetella pertussis in newborn piglets.Histidine-rich amphipathic peptide antibiotics promote efficient delivery of DNA into mammalian cells.pH modulates the activity and synergism of the airway surface liquid antimicrobials β-defensin-3 and LL-37 Effects of bacterial infection on airway antimicrobial peptides and proteins in COPD.The role of defensins in lung biology and therapy.Impact of Cardiopulmonary Bypass on Respiratory Mucociliary Function in an Experimental Porcine Model Osteopontin That Is Elevated in the Airways during COPD Impairs the Antibacterial Activity of Common Innate Antibiotics.Reduced airway surface pH impairs bacterial killing in the porcine cystic fibrosis lung.Lactoferrin regulates an axis involving CD11b and CD49d integrins and the chemokines MIP-1α and MCP-1 in GM-CSF-treated human primary eosinophils.In vivo airway surface liquid Cl- analysis with solid-state electrodes Antibacterial properties of the CFTR potentiator ivacaftor.Staphylococcus aureus exploits cathelicidin antimicrobial peptides produced during early pneumonia to promote staphylokinase-dependent fibrinolysis.Repurposing tromethamine as inhaled therapy to treat CF airway disease.Patterns and density of early tracheal colonization in intensive care unit patients.The cystic fibrosis neutrophil: a specialized yet potentially defective cell.

P2860

Q24291768-8FC50EB3-309E-4A46-B41D-391E6B4A1DE1 Q24541575-830D02A4-5A99-493C-9A35-96223C286F4D Q24548849-DA727634-F62A-4816-B2CA-F8AE320C00D4 Q24551612-B05276AE-8BE2-4250-ADC1-F017BE50B465 Q24559990-9E40186F-FDCF-4CEA-A81D-FE236735A670 Q24630137-94D48C5C-4CF8-4D66-92F8-0F90A84A7EEC Q24799101-E1E0CC6F-6F09-485B-AAE7-1F371CF1DC66 Q27667276-08057683-D00A-45C2-828E-8DC595073202 Q28391674-A807201C-BBAD-459A-B481-F70E9E16E8AA Q28395021-7979FC18-5DB9-4191-9571-772BCEC4C1F4 Q30080000-7E818DDB-FCC1-4DE6-AE2C-D52D7B20F626 Q30496665-962781A8-C891-42CC-956C-0F2D8FBE834F Q33303634-AE27169A-3474-410A-9527-0EEF6118F184 Q33478419-030F25FB-52DF-4EB9-9132-38C09BBADEE6 Q33583759-F928DBCB-EAA5-4373-8BD0-267FBEEB5BC1 Q33676038-33545622-C8EB-4C79-9948-DB40B9FF8388 Q33920973-4F2EB313-5FF9-42EB-846D-2E6F71CE563B Q33921035-DECB0AFC-5486-4876-84FE-69BAF00DC95E Q33988505-93F12DAA-0BD9-4C43-9674-C53F25DA9A24 Q33996589-F2307006-2182-4B6C-957F-371C925BC7E0 Q34004332-9B603FC8-A82F-4074-A978-FD47A498298C Q34007042-3AFCE6C5-14B8-4524-83FC-25C2C506358E Q34008714-8C9654BD-2481-402D-9E23-E2A2C38B96DD Q34125177-39CA5F65-F9F7-44AF-99FC-7021FCBD6D30 Q34348149-302C7644-1C3C-4C25-B305-8F7DEB61000F Q34492573-B15C566E-716D-4477-A862-AF60D059EE64 Q34760806-BF1BF0C9-B38F-467A-9B10-B42D3DDF4041 Q34832018-69F50027-3465-4B7B-A183-D82DD5D7B0EA Q35484510-868FE4F8-9DEE-4AC2-BEB4-4A35E225AA6E Q35627809-A82B702A-0237-4E13-9404-BDC2D25767DC Q35750282-85C4A068-9F21-4DEA-9DA9-048120DC6007 Q35885852-185FF8A4-BAFB-4FF3-9979-E77F05B468F7 Q36079160-345708A3-ED8C-4C90-8555-CF9990A9E750 Q36296976-4F8BDB8F-2E61-4E6E-ACCC-62C443732898 Q36445272-C4F63A28-D14A-4642-AF27-A4B94453C85E Q36479059-9D23318F-75E3-4C80-8336-84A25989BCF0 Q36631071-C2F58407-1A74-4C34-BDFF-B718F9A9B495 Q37066264-564AE21C-B535-4BA2-863A-ADE343693A48 Q37388541-20F3B703-FBAE-49FC-8615-D5DD213E03D0 Q37839809-536DC97C-9DA6-4C8E-BC1A-F89D54DF1608

P2860

Activity of abundant antimicrobials of the human airway.

http://www.wikidata.org/entity/Q33860518

description

1999 nî lūn-bûn

@nan

1999 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի մայիսին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

Activity of abundant antimicrobials of the human airway.

@ast

Activity of abundant antimicrobials of the human airway.

@en

type

label

Activity of abundant antimicrobials of the human airway.

@ast

Activity of abundant antimicrobials of the human airway.

@en

prefLabel

Activity of abundant antimicrobials of the human airway.

@ast

Activity of abundant antimicrobials of the human airway.

@en

P1433

Q33860518-680FC5B9-92FE-4F5B-BF15-F46E6F652F9C

P1476

Q33860518-E269E5E6-96D5-4C29-B4AD-B7335D5EB6F7

P2093

Q33860518-0F903743-946F-4EAC-B042-D691A01F2363

Q33860518-1DF39C0A-CE92-433E-85B3-F6F40C692AD0

Q33860518-37BFC8A0-5C23-4C04-9687-EB51914F5E20

Q33860518-6E04C738-5743-4EC5-8731-52348155E5EC

Q33860518-84B168EC-B21A-4959-808C-C45ED3ADC82A

Q33860518-9BA9D536-E6B8-40CA-90A5-C15C47A36A10

Q33860518-C192308C-C2E2-4B1B-886A-725908BBC8EC

Q33860518-C2AABBF8-EB8A-46A3-A899-229F32CFFA9D

P2860

Q33860518-07E297F8-4783-4DC5-8DBB-6E172F0008E1

Q33860518-0E158201-246C-4FB5-A8B6-A7062E7062C9

Q33860518-1266FD73-6E41-4692-8B6C-B4EED0C99472

Q33860518-12C16E04-05B3-4598-882D-90242ECAADA2

Q33860518-2A65350D-1244-4BCF-85D1-C10F6C9209DA

Q33860518-35637D91-F96D-47A3-90E9-29713F41D353

Q33860518-377BE339-4BB1-48DA-9220-E2172F323989

Q33860518-4646FF75-1AD4-4484-A03C-DCB06193C196

Q33860518-4C82FC3D-1B47-4AE9-AAB1-EDCF9BBFACDF

Q33860518-5353963B-9457-4B3E-85AD-6057062BD34A

P304

Q33860518-77072149-AD0F-4681-BB70-0B8540C427FB

P31

Q33860518-63B0DDEB-DE9B-44B2-B768-73191A6740D6

P356

Q33860518-08E2E277-31DD-4E4D-A572-8B1E3F8F6DA1

P433

Q33860518-87740F58-D28B-422C-B7D3-2C719930F90C

P478

Q33860518-BF5D0EFF-4970-4B5B-8766-A1CD73D94ABD

P577

Q33860518-EE118F74-4C55-4D15-9937-5E9A1B255A27

P698

Q33860518-8EBDBCB8-50C7-4E3D-8A58-D5C82573E813

P356

AJRCMB.20.5.3572

P1433

American Journal of Respiratory Cell and Molecular Biology

P1476

Activity of abundant antimicrobials of the human airway.

@en

P2093

Anderson NN

http://www.w3.org/2001/XMLSchema#string

Conway BA

http://www.w3.org/2001/XMLSchema#string

Greenberg EP

http://www.w3.org/2001/XMLSchema#string

Singh PK

http://www.w3.org/2001/XMLSchema#string

Smith JJ

http://www.w3.org/2001/XMLSchema#string

Travis SM

http://www.w3.org/2001/XMLSchema#string

Welsh MJ

http://www.w3.org/2001/XMLSchema#string

Zabner J

http://www.w3.org/2001/XMLSchema#string

P2860

Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung

Human beta-defensin-1: an antimicrobial peptide of urogenital tissues

The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface

Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis

Human airway epithelia express a beta-defensin

Aerosolized beclomethasone in chronic bronchitis. Improved pulmonary function and diminished airway inflammation

Anti-neutrophil elastase defense of the normal human respiratory epithelial surface provided by the secretory leukoprotease inhibitor.

Widespread expression of beta-defensin hBD-1 in human secretory glands and epithelial cells.

Pathophysiology of rhinitis. Lactoferrin and lysozyme in nasal secretions.

P304

872-879

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1165/AJRCMB.20.5.3572

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P577

1999-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10226057

http://www.w3.org/2001/XMLSchema#string